We propose that EZH2 acts as a tumour suppressor in all normal or premalignant cells, where it exerts its physiological function and cooperates with other epigenetic regulators to maintain proper cell identity in the face of cell‐extrinsic or intrinsic perturbations. Here, EZH2 is linked to neoplasm.